ClinicalTrials.gov record
Completed No phase listed Observational

Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib

ClinicalTrials.gov ID: NCT00812175

Public ClinicalTrials.gov record NCT00812175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 11:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00812175
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Bayer
Industry
Enrollment
3,371 participants

Conditions and interventions

Interventions

  • Sorafenib (Nexavar, BAY43-9006) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2008
Primary completion
Mar 31, 2012
Completion
Mar 31, 2012
Last update posted
Oct 16, 2016

2009 – 2012

United States locations

U.S. sites
37
U.S. states
37
U.S. cities
37
Facility City State ZIP Site status
Not listed Many Locations Alabama
Not listed Many Locations Arizona
Not listed Many Locations Arkansas
Not listed Many Locations California
Not listed Many Locations Colorado
Not listed Many Locations Connecticut
Not listed Many Locations Florida
Not listed Many Locations Georgia
Not listed Many Locations Hawaii
Not listed Many Locations Illinois
Not listed Many Locations Indiana
Not listed Many Locations Iowa
Not listed Many Locations Kansas
Not listed Many Locations Kentucky
Not listed Many Locations Louisiana
Not listed Many Locations Maryland
Not listed Many Locations Massachusetts
Not listed Many Locations Michigan
Not listed Many Locations Minnesota
Not listed Many Locations Missouri
Not listed Many Locations Nebraska
Not listed Many Locations Nevada
Not listed Many Locations New Hampshire
Not listed Many Locations New Jersey
Not listed Many Locations New York
Not listed Many Locations North Carolina
Not listed Many Locations Ohio
Not listed Many Locations Oklahoma
Not listed Many Locations Oregon
Not listed Many Locations Pennsylvania
Not listed Many Locations South Carolina
Not listed Many Locations Tennessee
Not listed Many Locations Texas
Not listed Many Locations Utah
Not listed Many Locations Virginia
Not listed Many Locations Washington
Not listed Many Locations Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00812175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2016 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00812175 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →